SCHEMBL23309593

SCHEMBL23309593

CC(C)Oc1cccc(NC(=O)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 2/20 0.52
▸ PLAU P00749 2/20 0.50
▸ F2 P00734 1/20 0.50
▸ PLG P00747 1/20 0.50
▸ PLAT P00750 1/20 0.50
▸ KLKB1 P03952 1/20 0.50
▸ PRSS1 P07477 1/20 0.50
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ KCNK3 O14649 2/20 0.47
▸ KCNK9 Q9NPC2 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ BRAF P15056 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ BRD4 O60885 2/20 0.44
▸ CREBBP Q92793 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309513 0.89 RAB9A (0.63) GRM4RAB9ANPC1KDM4EMEN1
SCHEMBL23309681 0.88 GRM4 (0.45) GRM4PLAUF2PLGPLAT
SCHEMBL23309645 0.88 ALDH1A1 (0.51) RAB9ANPC1KDM4EMEN1KMT2A
SCHEMBL23309511 0.86 KMT2A (0.52) PLAUKLKB1RAB9ANPC1KCNK3
SCHEMBL23309612 0.86 GRM4 (0.47) GRM4RAB9ANPC1KCNK3KCNK9
SCHEMBL23309585 0.85 KDM4E (0.52) GRM4PLAURAB9ANPC1KDM4E
SCHEMBL23309615 0.84 P2RX1 (0.58) GRM4RAB9ANPC1KCNK3KCNK9
SCHEMBL23309501 0.84 FADS1 (0.56) KCNK3KCNK9BRAFMEN1KMT2A
SCHEMBL23309536 0.82 MEN1 (0.55) RAB9ANPC1KCNK3KCNK9KDM4E
SCHEMBL23309627 0.82 PLAU (0.60) GRM4PLAUF2PLGPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL GRM4 2885/4885PLAU 4582/4885F2 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback